pI: 6.9588 |
Length (AA): 319 |
MW (Da): 36695 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 319 | 1gp6 (A) | 43 | 350 | 26.00 | 0 | 1 | 1.35 | -1.29 |
7 | 305 | 1odm (A) | 10 | 318 | 33.00 | 0 | 1 | 1.36 | -1.22 |
1 | 312 | 1odm (A) | 4 | 325 | 27.00 | 0 | 1 | 1.38236 | -1.04 |
6 | 280 | 1w9y (A) | 4 | 259 | 36.00 | 0 | 1 | 1.23387 | -0.59 |
6 | 274 | 5c3o (A) | 13 | 295 | 35.00 | 0.000036 | 1 | 1.27776 | -1.22 |
6 | 312 | 5c3q (A) | 13 | 333 | 33.00 | 0 | 1 | 1.44188 | -1.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126909)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G49620 | 2-oxoacid-dependent dioxygenase-like protein DIN11 |
Arabidopsis thaliana | AT1G47990 | gibberellin 2-oxidase 4 |
Arabidopsis thaliana | AT3G49630 | 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein |
Arabidopsis thaliana | AT1G78440 | gibberellin 2-beta-dioxygenase 1 |
Arabidopsis thaliana | AT3G50210 | 2-oxoglutarate-Fe(II)-dependent oxygenase domain-containing protein |
Arabidopsis thaliana | AT3G46490 | oxidoreductase, 2OG-Fe(II) oxygenase family protein |
Arabidopsis thaliana | AT1G35190 | 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein |
Arabidopsis thaliana | AT4G16770 | iron ion binding / oxidoreductase |
Arabidopsis thaliana | AT4G16765 | oxidoreductase, 2OG-Fe(II) oxygenase family protein |
Candida albicans | CaO19.541 | Fe II, 2-oxoglutarate-dependent dioxygenases |
Candida albicans | CaO19.8174 | Fe II, 2-oxoglutarate-dependent dioxygenases |
Candida albicans | CaO19.1306 | conserved hypothetical protein, similar to Fe II, 2-oxoglutarate-dependent dioxygenases |
Candida albicans | CaO19.8886 | conserved hypothetical protein, similar to Fe II, 2-oxoglutarate-dependent dioxygenases |
Dictyostelium discoideum | DDB_G0286201 | hypothetical protein |
Dictyostelium discoideum | DDB_G0277497 | hypothetical protein |
Dictyostelium discoideum | DDB_G0286203 | hypothetical protein |
Dictyostelium discoideum | DDB_G0283291 | hypothetical protein |
Drosophila melanogaster | Dmel_CG33099 | CG33099 gene product from transcript CG33099-RA |
Drosophila melanogaster | Dmel_CG33093 | CG33093 gene product from transcript CG33093-RA |
Drosophila melanogaster | Dmel_CG5346 | CG5346 gene product from transcript CG5346-RA |
Leishmania braziliensis | LbrM.29.0510 | thymine-7-hydroxylase, putative |
Leishmania donovani | LdBPK_290260.1 | thymine-7-hydroxylase, putative |
Leishmania infantum | LinJ.29.0260 | thymine-7-hydroxylase, putative;with=GeneDB:Tb927.7.7500 |
Leishmania major | LmjF.29.0250 | thymine-7-hydroxylase, putative;with=GeneDB:Tb927.7.7500 |
Leishmania mexicana | LmxM.08_29.0250 | oxidase-like protein |
Leishmania mexicana | LmxM.08_29.0251 | |
Oryza sativa | 4326767 | Os01g0188100 |
Oryza sativa | 4346490 | Os09g0245500 |
Oryza sativa | 4349154 | Os10g0522900 |
Oryza sativa | 4349156 | Os10g0523100 |
Oryza sativa | 4346502 | Os09g0248900 |
Trypanosoma brucei gambiense | Tbg972.7.8820 | iron/ascorbate oxidoreductase family protein |
Trypanosoma brucei gambiense | Tbg972.5.190 | iron/ascorbate oxidoreductase family protein, putative |
Trypanosoma brucei | Tb927.9.14600 | iron/ascorbate oxidoreductase family protein, putative |
Trypanosoma brucei | Tb927.7.7500 | thymine-7-hydroxylase, putative |
Trypanosoma brucei | Tb11.v5.0215 | iron/ascorbate oxidoreductase family protein, putative |
Trypanosoma brucei | Tb927.5.300 | thymine-7-hydroxylase, putative |
Trypanosoma congolense | TcIL3000_0_46870 | 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein, putative |
Trypanosoma congolense | TcIL3000_0_09620 | 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein, putative |
Trypanosoma cruzi | TcCLB.508409.160 | thymine-7-hydroxylase, putative |
Trypanosoma cruzi | TcCLB.510141.10 | thymine-7-hydroxylase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.7500 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.7500 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.7500 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.7500 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.5.300 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.300 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.300 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.300 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb09.211.4990 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.4990 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.4990 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.4990 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Tcru012735; Recombinant protein: full-length; Source: T cruzi; probable oxidoreductase PA0147 (imported) - Pseudomonas aeruginosa (strain PAO1) ; |